Mamguem Kanga 2020.
Study name | |
Methods | Randomised trial, France. |
Participants | Women with non‐metastatic hormone receptor‐positive breast cancer. |
Interventions | Health‐related quality of life assessment with delivery of scores to clinicians vs usual care. |
Outcomes | Primary outcome: compliance with endocrine therapy at 12 months. |
Starting date | |
Contact information | |
Notes | The study was funded by the Georges François LeClerc Center, Burgundy, France. |